BioCentury | Sep 14, 2017
Company News

Management tracks: SymCel, Taro, Akcea

...SymCel offers a cell-based assay for real-time monitoring of cell metabolism. Prescription and OTC pharma Taro Pharmaceutical Industries Ltd....
...International Inc. Kane Biotech Inc. Merus Labs International Inc. Norgine B.V. Rugen Therapeutics Co. Ltd. Sanofi Sun Pharmaceutical Industries Ltd. SymCel Sverige AB Taro Pharmaceutical Industries Ltd....
BioCentury | Dec 30, 2016
Emerging Company Profile

Mining for substitutions

...protein kininogen, which is in Phase II for acute external otitis. And NovaBiotics Ltd. and Taro Pharmaceutical Industries Ltd....
...Bethesda, Md. NovaBiotics Ltd., Aberdeen, U.K. Pergamum AB, Solna, Sweden Riptide Bioscience Inc., Vallejo, Calif. Taro Pharmaceutical Industries Ltd....
BioCentury | Dec 3, 2016
Company News

Management tracks

...Prescription and OTC pharma Taro Pharmaceutical Industries Ltd. (NYSE:TARO) said Uday Baldota will replace Kal Sundaram as its CEO...
BioCentury | Oct 31, 2016
Company News

Vanda, Taro Pharmaceutical deal

...schizophrenia in adults. Taro did not respond to inquiries. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Washington, D.C. Taro Pharmaceutical Industries Ltd....
BioCentury | Jul 1, 2016
Company News

Management tracks

...NASDAQ:AMRN) named Michael Kalb SVP and CFO. Kalb was CFO and chief accounting officer at Taro Pharmaceutical Industries Ltd....
BioCentury | Jan 6, 2014
Financial News

Taro financial update

...Sept. 30, 2013, the company had $710.9 million in cash. JPMorgan is the dealer manager. Taro Pharmaceutical Industries Ltd....
BioCentury | Dec 9, 2013
Financial News

Taro financial update

...of the company's outstanding shares. The deal closes Dec. 23. JPMorgan is the dealer manager. Taro Pharmaceutical Industries Ltd....
BioCentury | Sep 2, 2013
Company News

NovaBiotics, Taro deal

...undisclosed development. The partners could not be reached for details. NovaBiotics Ltd. , Aberdeen, U.K. Taro Pharmaceutical Industries Ltd....
BioCentury | Aug 19, 2013
Company News

Taro board of directors update

Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Haifa Bay, Israel Business: Pharmaceuticals Appointed: Dilip Shanghvi as chairman; he succeeds Kalyanasundaram Subramanian who becomes CEO, while remaining a director; Subramanian succeeds Interim CEO James Kedrowski, who remains a...
BioCentury | Apr 29, 2013
Clinical News

Topicort desoximetasone regulatory update

...spray to treat plaque psoriasis in adults. The product is a corticosteroid containing 0.25% desoximetasone. Taro Pharmaceutical Industries Ltd....
Items per page:
1 - 10 of 24
BioCentury | Sep 14, 2017
Company News

Management tracks: SymCel, Taro, Akcea

...SymCel offers a cell-based assay for real-time monitoring of cell metabolism. Prescription and OTC pharma Taro Pharmaceutical Industries Ltd....
...International Inc. Kane Biotech Inc. Merus Labs International Inc. Norgine B.V. Rugen Therapeutics Co. Ltd. Sanofi Sun Pharmaceutical Industries Ltd. SymCel Sverige AB Taro Pharmaceutical Industries Ltd....
BioCentury | Dec 30, 2016
Emerging Company Profile

Mining for substitutions

...protein kininogen, which is in Phase II for acute external otitis. And NovaBiotics Ltd. and Taro Pharmaceutical Industries Ltd....
...Bethesda, Md. NovaBiotics Ltd., Aberdeen, U.K. Pergamum AB, Solna, Sweden Riptide Bioscience Inc., Vallejo, Calif. Taro Pharmaceutical Industries Ltd....
BioCentury | Dec 3, 2016
Company News

Management tracks

...Prescription and OTC pharma Taro Pharmaceutical Industries Ltd. (NYSE:TARO) said Uday Baldota will replace Kal Sundaram as its CEO...
BioCentury | Oct 31, 2016
Company News

Vanda, Taro Pharmaceutical deal

...schizophrenia in adults. Taro did not respond to inquiries. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Washington, D.C. Taro Pharmaceutical Industries Ltd....
BioCentury | Jul 1, 2016
Company News

Management tracks

...NASDAQ:AMRN) named Michael Kalb SVP and CFO. Kalb was CFO and chief accounting officer at Taro Pharmaceutical Industries Ltd....
BioCentury | Jan 6, 2014
Financial News

Taro financial update

...Sept. 30, 2013, the company had $710.9 million in cash. JPMorgan is the dealer manager. Taro Pharmaceutical Industries Ltd....
BioCentury | Dec 9, 2013
Financial News

Taro financial update

...of the company's outstanding shares. The deal closes Dec. 23. JPMorgan is the dealer manager. Taro Pharmaceutical Industries Ltd....
BioCentury | Sep 2, 2013
Company News

NovaBiotics, Taro deal

...undisclosed development. The partners could not be reached for details. NovaBiotics Ltd. , Aberdeen, U.K. Taro Pharmaceutical Industries Ltd....
BioCentury | Aug 19, 2013
Company News

Taro board of directors update

Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Haifa Bay, Israel Business: Pharmaceuticals Appointed: Dilip Shanghvi as chairman; he succeeds Kalyanasundaram Subramanian who becomes CEO, while remaining a director; Subramanian succeeds Interim CEO James Kedrowski, who remains a...
BioCentury | Apr 29, 2013
Clinical News

Topicort desoximetasone regulatory update

...spray to treat plaque psoriasis in adults. The product is a corticosteroid containing 0.25% desoximetasone. Taro Pharmaceutical Industries Ltd....
Items per page:
1 - 10 of 24